nodes	percent_of_prediction	percent_of_DWPC	metapath
Betazole—HRH2—Monoamine GPCRs—DRD5—bipolar disorder	0.0636	0.0636	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD5—bipolar disorder	0.0534	0.0534	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—HTR1A—bipolar disorder	0.0371	0.0371	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—HTR2C—bipolar disorder	0.0358	0.0358	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—DRD1—bipolar disorder	0.0358	0.0358	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—DRD3—bipolar disorder	0.0347	0.0347	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—DRD4—bipolar disorder	0.0337	0.0337	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—DRD2—bipolar disorder	0.0314	0.0314	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0312	0.0312	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0308	0.0308	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0301	0.0301	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0301	0.0301	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0291	0.0291	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0283	0.0283	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0264	0.0264	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—DRD5—bipolar disorder	0.022	0.022	CbGpPWpGaD
Betazole—HRH2—Monoamine GPCRs—HTR2A—bipolar disorder	0.022	0.022	CbGpPWpGaD
Betazole—HRH2—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.0185	0.0185	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—ADM—bipolar disorder	0.0159	0.0159	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—TSHB—bipolar disorder	0.0155	0.0155	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—PDE4B—bipolar disorder	0.0155	0.0155	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—DRD1—bipolar disorder	0.0124	0.0124	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.0123	0.0123	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—ADCY2—bipolar disorder	0.011	0.011	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.0105	0.0105	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD5—bipolar disorder	0.008	0.008	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.0074	0.0074	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.0074	0.0074	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00715	0.00715	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00691	0.00691	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00691	0.00691	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00669	0.00669	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.0065	0.0065	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00613	0.00613	CbGpPWpGaD
Betazole—HRH2—G alpha (s) signalling events—POMC—bipolar disorder	0.00608	0.00608	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00605	0.00605	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00604	0.00604	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00592	0.00592	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00592	0.00592	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—ADM—bipolar disorder	0.00579	0.00579	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00573	0.00573	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—TSHB—bipolar disorder	0.00564	0.00564	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—TACR1—bipolar disorder	0.00564	0.00564	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00557	0.00557	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00518	0.00518	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DGKH—bipolar disorder	0.00494	0.00494	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—HTR1A—bipolar disorder	0.00467	0.00467	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—TAC1—bipolar disorder	0.0046	0.0046	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD5—bipolar disorder	0.00452	0.00452	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD1—bipolar disorder	0.00451	0.00451	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—HTR2C—bipolar disorder	0.00451	0.00451	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DGKH—bipolar disorder	0.00449	0.00449	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—RGS4—bipolar disorder	0.00444	0.00444	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD3—bipolar disorder	0.00437	0.00437	CbGpPWpGaD
Betazole—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00424	0.00424	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD4—bipolar disorder	0.00424	0.00424	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD5—bipolar disorder	0.00411	0.00411	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—RGS4—bipolar disorder	0.00403	0.00403	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—DRD2—bipolar disorder	0.00395	0.00395	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00363	0.00363	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—TRPC3—bipolar disorder	0.00343	0.00343	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—ADM—bipolar disorder	0.00327	0.00327	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—PDE4B—bipolar disorder	0.00319	0.00319	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—TSHB—bipolar disorder	0.00319	0.00319	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—TACR1—bipolar disorder	0.00319	0.00319	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—TRPC3—bipolar disorder	0.00311	0.00311	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—ADM—bipolar disorder	0.00297	0.00297	CbGpPWpGaD
Betazole—HRH2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.0029	0.0029	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—TSHB—bipolar disorder	0.00289	0.00289	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—PDE4B—bipolar disorder	0.00289	0.00289	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—TACR1—bipolar disorder	0.00289	0.00289	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—AKR1C4—bipolar disorder	0.00288	0.00288	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—HTR2A—bipolar disorder	0.00277	0.00277	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DGKH—bipolar disorder	0.00265	0.00265	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—HTR1A—bipolar disorder	0.00264	0.00264	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—TAC1—bipolar disorder	0.0026	0.0026	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—HTR2C—bipolar disorder	0.00255	0.00255	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD1—bipolar disorder	0.00255	0.00255	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD3—bipolar disorder	0.00247	0.00247	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD5—bipolar disorder	0.00243	0.00243	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—HTR1A—bipolar disorder	0.0024	0.0024	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD4—bipolar disorder	0.0024	0.0024	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—RGS4—bipolar disorder	0.00238	0.00238	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—TAC1—bipolar disorder	0.00236	0.00236	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—HTR2C—bipolar disorder	0.00231	0.00231	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD1—bipolar disorder	0.00231	0.00231	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—ADCY2—bipolar disorder	0.00225	0.00225	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD3—bipolar disorder	0.00224	0.00224	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—DRD2—bipolar disorder	0.00223	0.00223	CbGpPWpGaD
Betazole—HRH2—GPCR ligand binding—POMC—bipolar disorder	0.00221	0.00221	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD4—bipolar disorder	0.00217	0.00217	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—ADCY2—bipolar disorder	0.00205	0.00205	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—DRD2—bipolar disorder	0.00203	0.00203	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TRPC3—bipolar disorder	0.00184	0.00184	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADM—bipolar disorder	0.00175	0.00175	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TSHB—bipolar disorder	0.00171	0.00171	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—PDE4B—bipolar disorder	0.00171	0.00171	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TACR1—bipolar disorder	0.00171	0.00171	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—HTR2A—bipolar disorder	0.00156	0.00156	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—HTR2A—bipolar disorder	0.00142	0.00142	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HTR1A—bipolar disorder	0.00141	0.00141	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TAC1—bipolar disorder	0.00139	0.00139	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD1—bipolar disorder	0.00137	0.00137	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HTR2C—bipolar disorder	0.00137	0.00137	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NTRK2—bipolar disorder	0.00133	0.00133	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD3—bipolar disorder	0.00132	0.00132	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GSK3A—bipolar disorder	0.00132	0.00132	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD4—bipolar disorder	0.00128	0.00128	CbGpPWpGaD
Betazole—HRH2—GPCR downstream signaling—POMC—bipolar disorder	0.00125	0.00125	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—ADCY2—bipolar disorder	0.00121	0.00121	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—TCF7L2—bipolar disorder	0.00121	0.00121	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—DRD2—bipolar disorder	0.0012	0.0012	CbGpPWpGaD
Betazole—HRH2—Signaling by GPCR—POMC—bipolar disorder	0.00113	0.00113	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NTRK1—bipolar disorder	0.00108	0.00108	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—S100B—bipolar disorder	0.00105	0.00105	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—NRG1—bipolar disorder	0.00093	0.00093	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—HTR2A—bipolar disorder	0.000838	0.000838	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—GSK3B—bipolar disorder	0.000675	0.000675	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—POMC—bipolar disorder	0.000669	0.000669	CbGpPWpGaD
Betazole—HRH2—Signaling Pathways—INS—bipolar disorder	0.000666	0.000666	CbGpPWpGaD
